{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,17]],"date-time":"2026-11-17T07:20:00Z","timestamp":1794900000287,"version":"4.9.1"},"reference-count":20,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"32","license":[{"start":{"date-parts":[[2025,8,8]],"date-time":"2025-08-08T00:00:00Z","timestamp":1754611200000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2025,8,8]]},"abstract":"<jats:p>\n                    The pleural fluid macrophage ratio and mesothelial cell ratio are generally of limited diagnostic value. However, elevated ratios in some patients can complicate interpretation for physicians. This study evaluated the diagnostic utility of the pleural fluid macrophage ratio and mesothelial cell ratio across patients with various types of exudative pleural effusion. Data were retrospectively collected from 201 patients with tuberculous pleurisy, 243 with pleural infection, 432 with malignant pleural effusion, and 213 with other diseases at Fukujuji Hospital from January 2012 to June 2024. Comparisons of the pleural fluid macrophage ratio and mesothelial cell ratio were made among the 4 disease groups. Patients with malignant pleural effusion had a higher pleural fluid macrophage ratio (median 12.0%) than did those with tuberculous pleurisy (median 5.0%,\n                    <jats:italic toggle=\"yes\">P<\/jats:italic>\n                    \u2005&lt;\u2005.001), pleural infection (median 4.0%,\n                    <jats:italic toggle=\"yes\">P<\/jats:italic>\n                    \u2005&lt;\u2005.001), and other diseases (median 6.8%,\n                    <jats:italic toggle=\"yes\">P<\/jats:italic>\n                    \u2005&lt;\u2005.001). The pleural macrophage ratio was lower in pleural infection than in tuberculous pleurisy (\n                    <jats:italic toggle=\"yes\">P<\/jats:italic>\n                    \u2005=\u2005.010) or other diseases (\n                    <jats:italic toggle=\"yes\">P<\/jats:italic>\n                    \u2005&lt;\u2005.001). The pleural fluid mesothelial cell ratio was elevated in patients with malignant pleural effusion, although the median pleural fluid mesothelial cell ratio was 0% across all disease groups. Among patients with a pleural fluid macrophage ratio of\u2005\u2265\u200530% and a pleural mesothelial cell ratio of\u2005\u2265\u200510%, 82 patients (71.9%) and 22 patients (77.3%), respectively, were diagnosed with malignant pleural effusion. Extremely high levels of the pleural fluid macrophage ratio (\u226530%) and mesothelial cell ratio (\u226510%) suggest a diagnosis of malignant pleural effusion.\n                  <\/jats:p>","DOI":"10.1097\/md.0000000000043775","type":"journal-article","created":{"date-parts":[[2025,8,14]],"date-time":"2025-08-14T19:01:30Z","timestamp":1755198090000},"page":"e43775","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":0,"title":["High levels of the pleural fluid macrophage ratio and mesothelial cell ratio associated with malignant pleural effusion diagnosis: Observational study"],"prefix":"10.1097","volume":"104","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-2465-0118","authenticated-orcid":false,"given":"Masafumi","family":"Shimoda","sequence":"first","affiliation":[{"name":"Respiratory Disease Center, Fukujuji Hospital, Japan Anti-Tuberculosis Association (JATA), Kiyose, Tokyo, Japan."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yoshiaki","family":"Tanaka","sequence":"additional","affiliation":[{"name":"Respiratory Disease Center, Fukujuji Hospital, Japan Anti-Tuberculosis Association (JATA), Kiyose, Tokyo, Japan."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kozo","family":"Morimoto","sequence":"additional","affiliation":[{"name":"Respiratory Disease Center, Fukujuji Hospital, Japan Anti-Tuberculosis Association (JATA), Kiyose, Tokyo, Japan."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kozo","family":"Yoshimori","sequence":"additional","affiliation":[{"name":"Respiratory Disease Center, Fukujuji Hospital, Japan Anti-Tuberculosis Association (JATA), Kiyose, Tokyo, Japan."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ken","family":"Ohta","sequence":"additional","affiliation":[{"name":"Respiratory Disease Center, Fukujuji Hospital, Japan Anti-Tuberculosis Association (JATA), Kiyose, Tokyo, Japan."}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R2-20261117","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1002\/dc.2041","article-title":"Detection of monocyte\/macrophage cell populations in effusions: a comparative study using flow cytometric immunophenotyping and immunocytochemistry.","volume":"25","author":"Risberg","year":"2001","journal-title":"Diagn Cytopathol"},{"key":"R3-20261117","first-page":"964","article-title":"Pleural mesothelial cells in pleural and lung diseases.","volume":"7","author":"Batra","year":"2015","journal-title":"J Thorac Dis"},{"key":"R4-20261117","doi-asserted-by":"crossref","first-page":"1055","DOI":"10.1016\/j.mcna.2011.08.005","article-title":"Pleural effusions.","volume":"95","author":"Light","year":"2011","journal-title":"Med Clin North Am"},{"key":"R5-20261117","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1186\/s12890-022-02150-4","article-title":"Characteristics of pleural effusion with a high adenosine deaminase level: a case-control study.","volume":"22","author":"Shimoda","year":"2022","journal-title":"BMC Pulm Med"},{"key":"R6-20261117","doi-asserted-by":"crossref","first-page":"1779","DOI":"10.1111\/crj.12900","article-title":"Pleural tuberculosis: a concise clinical review.","volume":"12","author":"Shaw","year":"2018","journal-title":"Clin Respir J"},{"key":"R7-20261117","doi-asserted-by":"crossref","first-page":"822","DOI":"10.1136\/thoraxjnl-2011-201363","article-title":"Revisiting tuberculous pleurisy: pleural fluid characteristics and diagnostic yield of mycobacterial culture in an endemic area.","volume":"67","author":"Ruan","year":"2012","journal-title":"Thorax"},{"key":"R8-20261117","doi-asserted-by":"crossref","first-page":"1161375","DOI":"10.3389\/fimmu.2023.1161375","article-title":"Macrophage-derived exosome promotes regulatory T cell differentiation in malignant pleural effusion.","volume":"14","author":"Shao","year":"2023","journal-title":"Front Immunol"},{"key":"R9-20261117","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1016\/j.immuni.2014.06.010","article-title":"Tumor-associated macrophages: from mechanisms to therapy.","volume":"41","author":"Noy","year":"2014","journal-title":"Immunity"},{"key":"R10-20261117","doi-asserted-by":"crossref","first-page":"1755","DOI":"10.1016\/j.jtho.2016.06.021","article-title":"Pleural effusion of patients with malignant mesothelioma induces macrophage-mediated T cell suppression.","volume":"11","author":"Lievense","year":"2016","journal-title":"J Thorac Oncol"},{"key":"R11-20261117","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1038\/nrc1256","article-title":"Tumour-educated macrophages promote tumour progression and metastasis.","volume":"4","author":"Pollard","year":"2004","journal-title":"Nat Rev Cancer"},{"key":"R12-20261117","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1016\/j.resinv.2023.11.005","article-title":"Diagnostic flowchart for tuberculous pleurisy, pleural infection, and malignant pleural effusion.","volume":"62","author":"Shimoda","year":"2024","journal-title":"Respir Investig"},{"key":"R13-20261117","doi-asserted-by":"crossref","first-page":"963","DOI":"10.1016\/j.resinv.2024.08.010","article-title":"Validation of a diagnostic flowchart for tuberculous pleurisy in pleural fluid with high levels of adenosine deaminase.","volume":"62","author":"Shimoda","year":"2024","journal-title":"Respir Investig"},{"key":"R14-20261117","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1007\/s11748-010-0599-6","article-title":"Surgical treatment of chronic empyema.","volume":"58","author":"Shiraishi","year":"2010","journal-title":"Gen Thorac Cardiovasc Surg"},{"key":"R15-20261117","doi-asserted-by":"crossref","first-page":"2569","DOI":"10.1002\/art.27584","article-title":"2010 rheumatoid arthritis classification criteria: an American College of Rheumatology\/European League Against Rheumatism collaborative initiative.","volume":"62","author":"Aletaha","year":"2010","journal-title":"Arthritis Rheum"},{"key":"R16-20261117","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1016\/S0140-6736(05)66990-5","article-title":"Sjogren\u2019s syndrome.","volume":"366","author":"Fox","year":"2005","journal-title":"Lancet"},{"key":"R17-20261117","doi-asserted-by":"crossref","first-page":"21","DOI":"10.3109\/s10165-011-0571-z","article-title":"Comprehensive diagnostic criteria for IgG4-related disease (IgG4-RD), 2011.","volume":"22","author":"Umehara","year":"2012","journal-title":"Mod Rheumatol"},{"key":"R18-20261117","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1016\/j.anl.2020.07.004","article-title":"Clinical characteristics, the diagnostic criteria and management recommendation of otitis media with antineutrophil cytoplasmic antibody (ANCA)-associated vasculitis (OMAAV) proposed by Japan Otological Society.","volume":"48","author":"Harabuchi","year":"2021","journal-title":"Auris Nasus Larynx"},{"key":"R19-20261117","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1007\/s00408-018-0090-1","article-title":"Diagnostic value of vascular endothelial growth factor, transforming growth factor-beta, interleukin-8, and the ratio of lactate dehydrogenase to adenosine deaminase in pleural effusion.","volume":"196","author":"Saraya","year":"2018","journal-title":"Lung"},{"key":"R20-20261117","doi-asserted-by":"crossref","first-page":"452","DOI":"10.1038\/bmt.2012.244","article-title":"Investigation of the freely available easy-to-use software \u201cEZR\u201d for medical statistics.","volume":"48","author":"Kanda","year":"2013","journal-title":"Bone Marrow Transplant"},{"key":"R21-20261117","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1111\/cyt.12808","article-title":"Number of mesothelial cells as a measure of adequacy criteria for pleural effusions: a multi-institutional study.","volume":"31","author":"Rodriguez","year":"2020","journal-title":"Cytopathology"}],"container-title":["Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/10.1097\/MD.0000000000043775","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,11,17]],"date-time":"2026-11-17T07:01:47Z","timestamp":1794898907000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/10.1097\/MD.0000000000043775"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,8,8]]},"references-count":20,"journal-issue":{"issue":"32","published-print":{"date-parts":[[2025]]}},"URL":"https:\/\/doi.org\/10.1097\/md.0000000000043775","relation":{},"ISSN":["1536-5964","0025-7974"],"issn-type":[{"value":"1536-5964","type":"electronic"},{"value":"0025-7974","type":"print"}],"subject":[],"published":{"date-parts":[[2025,8,8]]},"assertion":[{"value":"2025-04-20","name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2025-07-18","name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}}]}}